Marc Panoff - Sep 10, 2025 Form 4 Insider Report for LB PHARMACEUTICALS INC (LBRX)

Signature
/s/ Marc Panoff
Stock symbol
LBRX
Transactions as of
Sep 10, 2025
Transactions value $
$0
Form type
4
Date filed
9/29/2025, 08:16 PM

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PANOFF MARC L Senior Vice President, Finance C/O LB PHARMACEUTICALS INC, ONE PENNSYLVANIA PLAZA, SUITE 1025, NEW YORK /s/ Marc Panoff 2025-09-12 0001304340

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBRX Employee Stock Option (Right to Buy) Disposed to Issuer -3.94K -100% 0 Sep 10, 2025 Common Stock 3.94K $64.15 Direct F1, F2
transaction LBRX Employee Stock Option (Right to Buy) Award +3.94K 3.94K Sep 10, 2025 Common Stock 3.94K $15.00 Direct F1, F2
transaction LBRX Employee Stock Option (Right to Buy) Disposed to Issuer -896 -100% 0 Sep 10, 2025 Common Stock 896 $69.72 Direct F1, F2
transaction LBRX Employee Stock Option (Right to Buy) Award +896 896 Sep 10, 2025 Common Stock 896 $15.00 Direct F1, F2
transaction LBRX Employee Stock Option (Right to Buy) Disposed to Issuer -1.26K -100% 0 Sep 10, 2025 Common Stock 1.26K $69.72 Direct F1, F2
transaction LBRX Employee Stock Option (Right to Buy) Award +1.26K 1.26K Sep 10, 2025 Common Stock 1.26K $15.00 Direct F1, F2
transaction LBRX Employee Stock Option (Right to Buy) Disposed to Issuer -14.3K -100% 0 Sep 10, 2025 Common Stock 14.3K $41.84 Direct F2, F3
transaction LBRX Employee Stock Option (Right to Buy) Award +14.3K 14.3K Sep 10, 2025 Common Stock 14.3K $15.00 Direct F2, F3
transaction LBRX Employee Stock Option (Right to Buy) Disposed to Issuer -7.17K -100% 0 Sep 10, 2025 Common Stock 7.17K $41.84 Direct F2, F4
transaction LBRX Employee Stock Option (Right to Buy) Award +7.17K 7.17K Sep 10, 2025 Common Stock 7.17K $15.00 Direct F2, F4
transaction LBRX Employee Stock Option (Right to Buy) Award $0 +90.5K $0.00 90.5K Sep 10, 2025 Common Stock 90.5K $15.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 The transactions reported herein reflect a one-time stock option repricing, effective on September 10, 2025, which reduced the per share exercise price of each repriced option to $15, representing the initial public offering price of the Issuer's common stock (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the repriced options, including, without limitation, any provisions with respect to vesting, remain in full force and effect.
F3 One fourth (1/4) of the shares subject to the option award vested on August 25, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F4 One fourth (1/4) of the shares subject to the option award vested on June 28, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F5 One fourth (1/4) of the shares subject to the option award shall vest on September 10, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.